Cargando…
Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway
Background: Prostate cancer is the most common malignant tumor in men, accounting for one of the top five cancer incidences worldwide. However, there is no effective pharmacological treatment for advanced prostate cancer (APC). Herein, we aim to investigate the mechanism of Zhoushi Qiling decoction...
Autores principales: | Cao, Hongwen, Feng, Yigeng, Sun, Peng, Chen, Lei, Wang, Dan, Gao, Renjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414038/ https://www.ncbi.nlm.nih.gov/pubmed/37576403 http://dx.doi.org/10.7150/jca.84943 |
Ejemplares similares
-
Zhoushi Qiling decoction induces apoptosis of human prostate cancer cells via miR-143/Bcl-2 axis
por: Cao, Hongwen, et al.
Publicado: (2021) -
QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo
por: Cao, Hongwen, et al.
Publicado: (2023) -
Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
por: Cao, Hongwen, et al.
Publicado: (2022) -
Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis
por: Cao, Hongwen, et al.
Publicado: (2021) -
TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway
por: Cao, Hongwen, et al.
Publicado: (2020)